Get started

Breakoutzone

ROSSARI BIOTECH Showing Change in Price StructureNSE:ROSSARI .................................................................................................................... .................................................................................................................... .................................................................................................................... Update on the expansion projects at Dahej Facilities .................................................................................................................... • In the Q2FY24 the Company had announced an expansion of its facility at Dahej by adding up 20,000 MTPA capacity for products related to HPPC in the specialty chemical space, as well as for producing ingredients for its subsidiary companies. Also, to cater to the growing demand in agro chemicals, home and personal care, oil & gas and the pharma sector, the Company had further announced expansion of the Ethoxylation capacity by 30,000 MTPA at the Dahej facility of Unitop Chemicals Private Limited. • Work on both these projects are progressing as planned. Commissioning is expected to happen, in a phased manner in the current year .................................................................................................................... .................................................................................................................... .................................................................................................................... • Consistent growth trajectory over the past three years, driven by both organic and inorganic growth strategies • While near-term investments and strategic initiatives have led to a moderation in ROCE and ROE, the balance sheet position remains strong. The Company is confident of reporting improved return metrics in the future as these investments start yielding results
NSE:ROSSARILong
by iism-ExpertTrading
SWSOLAR Getting Ready to Break its 2019's & All Time HighNSE:SWSOLAR ................................................................................................................. ................................................................................................................. ................................................................................................................. | KEY HIGHLIGHTS FOR 1Q FY25 ............................................................................... • Unexecuted order value at ~INR 9,396 crore as of June 2024 compared to ~INR 8,084 crore as of Mar 2024 • Company has received new orders / LOI in three domestic projects worth ~INR 1,016 crore during the quarter • Company received two turnkey international orders from South Africa amounting to ~USD 140 mn • Commenced a pilot project for Solar plus BESS for Reliance Industries at Jamnagar, Gujarat • P&L of the company continues to improve • Consol revenues up ~78% YoY in 1QFY25 • Gross margins at ~11% • Second consecutive quarter of positive EBITDA, PBT and PAT at a consolidated level ............................................................................................................ • The company’s balance sheet continues to de-leverage ............................................................................................................ • Total net debt of ~INR 97 crore as of Jun 2024, compared to net debt of ~INR 116 crore in Mar 2024 • No upcoming debt repayments till 3QFY25 ................................................................................................................. ................................................................................................................. ................................................................................................................. Received order of 900 MW DC in 1QFY25 • Received a turnkey solar PV order from AMEA Power in South Africa for a ~140 MW DC project • Through this project, SWREL has achieved a key breakthrough in the rapidly growing South African solar market. • We have successfully executed a 90 MW DC order in South Africa in 2016 previously, and continue to maintain O&M operations there • Bagged our second international order from South Africa with a turnkey package for a 80 MW AC project from Energy Group ................................................................................................................. ................................................................................................................. .................................................................................................................
NSE:SWSOLARLong
by iism-ExpertTrading
ALKYLAMINE is Reacting & Showing Change in Structure & STORYNSE:ALKYLAMINE ............................................................................................................................................................................................................................................ TURN-AROUND STORY IS IN PROGRES IN TERMS OF PRODUCTION FACILITY AND SUSTAINABLE PRODUCT WHICH WILL BE ABLE COMPETE CHINESE COMPATETORS ............................................................................................................................................................................................................................................ Company has reduced debt. Company is almost debt free. Company has a good return on equity (ROE) track record: 3 Years ROE 19.0%. Company has been maintaining a healthy dividend payout of 26.5%. ............................................................................................................................................................................................................................................ Strong financial risk profile and ample liquidity: Networth was healthy at Rs. 1263 crores as on March 31, 2024 (Rs 1165 crore as on March 31, 2023), with nil gearing as on March 31, 2024.The total outside liabilities to adjusted networth (TOL/ANW) ratio though had decreased to 0.25 time as on March 31, 2024 from 0.36 times as on March 31, 2023, and it is expected to improve over the medium term driven by steady accretion to reserves, absence of long term loans and moderate reliance on external debt for working capital and capex. Cash and cash equivalents of Rs 17 crore as on March 31, 2024, provide cushion to overall liquidity. Interest coverage ratio has improved to 60.4 times March 31, 2024. It is expected to remain healthy over the medium term. ............................................................................................................................................................................................................................................
NSE:ALKYLAMINELong
by iism-ExpertTrading
PFOCUS is Focusing on 2008's Multi-Year Long Resistance BreakoutNSE:PFOCUS ............................................................................................................................................. ............................................................................................................................................. Over Last 4 Years ... From Year 2020 to 2024 Promoter Holdings Have Been Increased by +34.93% ...... ............................................................................................................................................. ............................................................................................................................................. Customers PFL caters to players across the entire media industry value chain and the product life cycle of media content. Its major clients include top Hollywood and Indian studios and media companies across the globe: Studios – Warner Bros., Disney, Netflix, etc. Broadcast networks – Bloomberg, Disney, Star, etc. Others – ICC, BCCI, Amazon, etc. ............................................................................................................................................. ............................................................................................................................................. Focus In Creative Services, it aims to expand its global footprint and diversify the business across content formats. It also expects growth in cross-selling through bundled VFX, etc. In Tech/Tech-Enabled Services it aims to sign more strategic deals and increase revenue from existing clients by offering new modules and analytics. Working on top Hollywood projects One of them is Matrix 4
NSE:PFOCUSLong
by iism-ExpertTrading
IOLCP Showing Change in Structure can go towards 52 Week HighNSE:IOLCP ...................................................................................................................... ...................................................................................................................... The Company’s turnover increased to ₹ 2,133 crore in FY24 from ₹ 983 crore in FY18 at a CAGR of 13.77% ...................................................................................................................... ...................................................................................................................... The share of regulated market sale has increased to ₹ 300 crore in FY24 from ₹100 crore in FY18 ...................................................................................................................... ...................................................................................................................... Increased contribution of non-Ibuprofen drugs from ₹35 crore in FY18 to ₹431 crore in FY24, showing a steady upward trend over the years ...................................................................................................................... ...................................................................................................................... Added more than 10 products since 2017 in APIs and chemical segments. The Company has recently commenced a new plant of Acetic Anhydride ...................................................................................................................... ...................................................................................................................... • The Indian API market is expected to grow at a CAGR of 13.7% over the four years. • India hosts 500 API manufacturers, contributing approximately 8% to the global API Industry. • As the largest supplier of generic medicines, India manufactures around 60,000 different generic brands across 60 therapeutic categories. • In FY24 India saw a 4.12% increase in the total imports of bulk drugs and intermediates, amounting to ₹ 37,721.88 crore, compared to ₹ 36,229.15 crore in FY23. • Indian medicines are preferred worldwide due to their combination of low price and high quality, earning India the title of "pharmacy of the world." ...................................................................................................................... ...................................................................................................................... Positive factors • Strongly improving operating performance, resulting in growth of more than 15% in total operating income and sustained EBIDTA margin of more than 20%, on a sustained. • Diversifying product portfolio and reducing dependency on its main product Ibuprofen and ethyl acetate to below 65% in the overall revenue. • Improving total debt to gross cash accruals (TD/GCA) and TD to profit before interest, lease rentals, depreciation, and taxation (TD/PBILDT) to below unity. ...................................................................................................................... ...................................................................................................................... Established market position and diversified product offering The company was incorporated, 1986 with the commencement of business in chemical segment. In 2000, the company started production of Ibuprofen. IOLCPL is one of the largest manufacturers of Ibuprofen with significant global share and the company is backward integrated for manufacturing Ibuprofen. IOLCPL has a market presence across more than 50 countries with sales contribution from exports forming around 28% of total sales in FY24 (PY: 29%). The company’s overseas customers are spread across Switzerland, Bangladesh, Spain, Indonesia, Hungary, United Kingdom, Nepal, China, Turkey and Japan, among others. The company is one of the largest manufacturers of Ibuprofen (capacity of 12000 MTPA) and has the second largest manufacturing capacity (12000MTPA) for Iso Butyl Benzene (key raw material for Ibuprofen)
NSE:IOLCPLong
by iism-ExpertTrading
RUPA indicating is No More an Ordinary Underwear BrandNSE:RUPA Commenting on the financial performance Mr. Vikash Agarwal - Whole Time Director, said, “We are pleased to report a stable performance in Q1 FY25, though the industry continues to witness resistance to any price increase. We demonstrated steady improvements across key financial metrics. This quarter, we witnessed 8% rise in revenue, primarily driven by strong sales in our core product line. Our volume growth for the quarter reached 9%, supported by strong sales in the economy and athleisure segments. Our EBITDA saw a year-on-year increase of 59%, totaling Rs. 18.0 crores for the quarter, showcasing our commitment to cost management and operational efficiency. Operating margins also improved by 280 basis points compared to the same period last year. Furthermore, our net profit experienced substantial growth of 149%, reaching Rs. 10.5 crores for the quarter. This underscores the effectiveness of our financial strategies and the resilience of our business model. Net profit margins improved by 280 basis points during the quarter. Notably, our exports have shown progress, with a healthy 32% year-on-year growth, reaching Rs. 8 crores. This reflects our steady penetration into international markets. Revenue contribution from Modern Trade remains robust at 8% in Q1 FY25. The pilot project “Pragati’, which was launched last quarter, has received encouraging feedback from our distributors. We expect healthy expansion of the project going forward. Our cash flow from operations remains strong, generating Rs. 44 crores in Q1 FY25. We have made significant progress in reducing our debt, achieving a net debt-free status as at end of Q1 FY25. Our branding and advertising strategies accounted for 9% of revenues in Q1 FY25. Looking ahead, we are confident in achieving new business milestones and delivering innovative products to our diverse customer segments. Our customer-first approach will help us strengthen our position as an industry leader and contribute to our sustainable business model
NSE:RUPALong
by iism-ExpertTrading
Boring Stock, Getting Close to a Potential Long-Term BreakoutWaiting for a monthly close above the 8-year downtrend line to get in. The chart is pretty messy but many other signals are converging around that area (200-month EMA, 50-month EMA, .382 Fib). Price had a false breakout early in the downtrend based on the trendline I drew but I drew it where it is because it had many hits along this line. If price breaks out here I think it's significant because it would also be breaking above the 200-month EMA after dipping below temporarily (which it hadn't done for a really long time). I'm waiting for a monthly close above the 200-month EMA to start a position, and will plan on adding more if it can get about the 50-month EMA. I don't have a stop loss, this is a long-term buy and hold and collect the dividends if it can breakout. If it has a false breakout and goes down, I'll just buy up more at certain intervals and will update this idea. I think from looking at this chart and reading/listening to some of the other ideas about this stock that it can surpass the highs it made about 8 years ago and my price target is $270-$300 where I would start to think about using a stop loss and protecting profit. I like using stop losses eventually because it can let a stock potentially run rather than just selling when it hits the target. Anyway, waiting for another week to make a decision. If price ends up failing here, I think I will probably be able to get in down around $100 or maybe even a bit lower and I would consider starting a position there but I like buying on breakouts rather than trying to catch a "falling knife". One more thing on this stock, it hasn't participated much in the market recovery since the March lows from the covid panic selloff and that makes me like it also (just look at a long-term chart of Microsoft after the tech bubble, for a long time it pretty much traded sideways and now look at it, I'm not saying IBM will do the same but it could, I'm not one to limit the potential of the stock market long-term, over long periods of time it goes up on average). **These are just notes about what I am personally considering doing and are not recommendations to trade. If you decide to follow any of this, trade at your own risk and keep a long-term perspective, I'm talking this trade could take the better part of a decade to play out (not weeks or months, that would be a short-term trade which is usually not for me).**
NYSE:IBMLong
by PatientContrarian
3
Dow Jones Industrials suddenly not looking too shabbyThe Dow Jones has been out on vacation for the first half of this year, not really participating in the melt-up, and instead, consolidating and working off that sharp rally from Q4 2022. After all, it was one of the first indexes to bottom from the depths of the bear and start leading things higher. But now after all of this sideways consolidation, it's starting to offer up a favorable reward-to-risk if it can build momentum over 34,500. Perhaps a possible rotation into YTD leaders and back into industrials for the second half of the year? I'm not so sure about that yet, but it's a chart worth paying attention to.
TVC:DJI
by EvanMedeiros
2
NIFTYPSE INDEX >>MAKE OR BREAK LEVEL ??Hello to everyone NIFTY PSE INDEX Trading near all time level Of 4687 and strong resistance zone of 4380-- 4580. This zone is acted as strong resistance in past trading sessions. Price resisted number of time at this zone and slopes down towards the support zone . If price able to break this zone and ATH level than we can see new all time high level of the nifty pse index , and if price respects the resistance zone than price again slopes down. As per the chart setup , Here the higher probability of that price will breach the resistance zone and ATH level and will makes new high price. If this breakout happen than all PSE Stocks can show good momentum and can give good returns Traders, if you liked this idea or if you have your own opinion about it, write in the comments. I will be glad.
NSE:CNXPSE
by Jha_Nidhi
💥 3 Types of BreakoutIn trading, the term "breakout" refers to a price movement that "breaks" past a certain level or range. It's important to note that breakouts can be false, meaning the price could reverse its movement after the breakout. Hence, traders often use confirmation techniques to confirm the validity of a breakout. A breakout is a potential trading opportunity that occurs when an asset's price moves above a resistance level or moves below a support level on increasing volume. The first step in trading breakouts is to identify current price trend patterns along with support and resistance levels in order to plan possible entry and exit points. Once you've acted on a breakout strategy, know when to cut your losses and re-assess the situation if the breakout sputters. As with any technical trading strategy, don't let emotions get the better of you. Stick with your plan and know when to get in and get out. 📈3 Key things to know about Breakouts📉 📍A breakout in the stock market refers to a situation where the price of a security moves beyond a pre-defined support or resistance level, accompanied by an increase in trading volume. Traders often take advantage of breakouts by entering a long position when the price surpasses resistance or a short position when it falls below support. This movement beyond a price barrier often leads to increased volatility and a trend in the direction of the breakout. 📍Breakouts are highly valued as a trading strategy because they can signal the beginning of heightened volatility, substantial price movements, and major trends. This phenomenon can occur in various market conditions and is particularly noticeable in the case of channel breakouts and price pattern breakouts, such as triangles, flags, or head and shoulders patterns. As volatility contracts during these periods, it typically expands once the prices move beyond the established range. 📍Breakout trading can be applied to various trading styles and timeframes, including intraday, daily, or weekly charts, making it a versatile strategy for day trading, swing trading, or any other approach. 🔹 Trend Line Breakout: This occurs when the price breaks past a trend line that has been connecting a series of lows or highs. 🔹 Support and Resistance Breakout: This occurs when the price breaks past a significant level of support or resistance. 🔹 Flag and Pennant Breakout: This occurs when the price breaks past a flag or pennant pattern, which is a short-term consolidation pattern. 🔹 Rectangle Breakout: This occurs when the price breaks past a rectangular price pattern, which is a pattern of price congestion. 🔹 Volume Breakout: This occurs when the volume of trades surpasses a significant level, indicating a potential change in trend. It's important to note that breakouts can be false, meaning the price could reverse its movement after the breakout. Hence, traders often use confirmation techniques to confirm the validity of a breakout. 👤 @AlgoBuddy 📅 Daily Ideas about market update, psychology & indicators ❤️ If you appreciate our work, please like, comment and follow ❤️
Education
by QuantVue
20